Skip to Content
Merck
CN
  • TGFBR1*6A is not associated with prostate cancer in men of European ancestry.

TGFBR1*6A is not associated with prostate cancer in men of European ancestry.

Prostate cancer and prostatic diseases (2004-10-27)
B K Suarez, P Pal, C H Jin, R Kaushal, G Sun, L Jin, B Pasche, R Deka, W J Catalona
ABSTRACT

The TGFBR1*6A (*6A) variant in exon 1 of the TGFBR1 gene has been postulated as a putative tumor susceptibility allele in several studies. We have performed a case-control study in 537 men with histologically verified prostate cancer and in 488 unrelated controls to investigate the association of *6A with prostate cancer. Our results revealed that the frequency of the (*)6A allele does not differ in men with prostate cancer compared to healthy controls, even in a subset of age-matched cases and controls. There is no compelling evidence for an association of the *6A variant with prostate cancer.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
TGFβR1 (80-end), GST tagged human, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution